{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:45:45Z","timestamp":1791405945314,"version":"4.3.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T00:00:00Z","timestamp":1424908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1208\/s12248-015-9739-3","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T17:24:44Z","timestamp":1424885084000},"page":"652-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Influence of P-Glycoprotein Inhibition or Deficiency at the Blood\u2013Brain Barrier on 18F-2-Fluoro-2-Deoxy-d-glucose (18F-FDG) Brain Kinetics"],"prefix":"10.1208","volume":"17","author":[{"given":"Nicolas","family":"Tournier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadad","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Goutal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ric","family":"Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Scherrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bottlaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cisternino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,26]]},"reference":[{"key":"9739_CR1","first-page":"885","volume":"47","author":"D Delbeke","year":"2006","unstructured":"Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure guideline for tumor imaging with 18F-FDG PET\/CT 1.0. J Nucl Med. 2006;47:885\u201395.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"9739_CR2","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.2967\/jnumed.108.057224","volume":"50","author":"L-F Geus-Oei De","year":"2009","unstructured":"De Geus-Oei L-F, Vriens D, van Laarhoven HWM, van der Graaf WTA, Oyen WJG. Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review. J Nucl Med. 2009;50 Suppl 1:43S\u201354.","journal-title":"J Nucl Med"},{"key":"9739_CR3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2967\/jnumed.108.054205","volume":"50","author":"S Ben-Haim","year":"2009","unstructured":"Ben-Haim S, Ell P. 18F-FDG PET and PET\/CT in the Evaluation of Cancer Treatment Response. J Nucl Med. 2009;50:88\u201399.","journal-title":"J Nucl Med"},{"key":"9739_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2967\/jnumed.112.107375","volume":"54","author":"GJR Cook","year":"2013","unstructured":"Cook GJR, Yip C, Siddique M, Goh V, Chicklore S, Roy A, et al. Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med. 2013;54:19\u201326.","journal-title":"J Nucl Med"},{"key":"9739_CR5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","volume":"36","author":"A Varrone","year":"2009","unstructured":"Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, N\u00e5gren K, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2103\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9739_CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/WNL.0b013e31829d86e8","volume":"81","author":"GB Frisoni","year":"2013","unstructured":"Frisoni GB, Bocchetta M, Ch\u00e9telat G, Rabinovici GD, de Leon MJ, Kaye J, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 2013;81:487\u2013500.","journal-title":"Neurology"},{"key":"9739_CR7","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2967\/jnumed.110.075390","volume":"51","author":"A Kumar","year":"2010","unstructured":"Kumar A, Juh\u00e1sz C, Asano E, Sood S, Muzik O, Chugani HT. Objective detection of epileptic foci by 18F-FDG PET in children undergoing epilepsy surgery. J Nucl Med. 2010;51:1901\u20137.","journal-title":"J Nucl Med"},{"key":"9739_CR8","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2967\/jnumed.108.054098","volume":"50","author":"H Jadvar","year":"2009","unstructured":"Jadvar H, Alavi A, Gambhir SS. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med. 2009;50:1820\u20137.","journal-title":"J Nucl Med"},{"key":"9739_CR9","first-page":"675","volume":"46","author":"S Zhao","year":"2005","unstructured":"Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, et al. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med. 2005;46:675\u201382.","journal-title":"J Nucl Med"},{"key":"9739_CR10","first-page":"930","volume":"45","author":"N Avril","year":"2004","unstructured":"Avril N. GLUT1 expression in tissue and (18)F-FDG uptake. J Nucl Med. 2004;45:930\u20132.","journal-title":"J Nucl Med"},{"key":"9739_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0969-8051(00)00177-3","volume":"28","author":"TA Smith","year":"2001","unstructured":"Smith TA. The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation. Nucl Med Biol. 2001;28:1\u20134.","journal-title":"Nucl Med Biol"},{"key":"9739_CR12","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/jnr.22738","volume":"89","author":"K Devraj","year":"2011","unstructured":"Devraj K, Klinger ME, Myers RL, Mokashi A, Hawkins RA, Simpson IA. GLUT-1 glucose transporters in the blood\u2013brain barrier: differential phosphorylation. J Neurosci Res. 2011;89:1913\u201325.","journal-title":"J Neurosci Res"},{"key":"9739_CR13","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13:714\u201326.","journal-title":"Nat Rev Cancer"},{"key":"9739_CR14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.nucmedbio.2007.07.007","volume":"34","author":"TAD Smith","year":"2007","unstructured":"Smith TAD, Sharma RI, Wang WG, Welch AE, Schweiger LF, Collie-Duguid ESR. Decreased [18F]fluoro-2-deoxy-d-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro. Nucl Med Biol. 2007;34:955\u201360.","journal-title":"Nucl Med Biol"},{"key":"9739_CR15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1346-8138.2005.tb00904.x","volume":"32","author":"K Yamada","year":"2005","unstructured":"Yamada K, Brink I, Engelhardt R. Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) accumulation in melanoma cells: is FDG a substrate of multidrug resistance (MDR)? J Dermatol. 2005;32:335\u201345.","journal-title":"J Dermatol"},{"key":"9739_CR16","first-page":"646","volume":"42","author":"DE Lorke","year":"2001","unstructured":"Lorke DE, Kr\u00fcger M, Buchert R, Bohuslavizki KH, Clausen M, Schumacher U. In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line. J Nucl Med. 2001;42:646\u201354.","journal-title":"J Nucl Med"},{"key":"9739_CR17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.nucmedbio.2011.12.007","volume":"39","author":"C Yu","year":"2012","unstructured":"Yu C, Wan W, Zhang B, Deng S, Yen T-C, Wu Y. Evaluation of the relationship between [18F]FDG and P-glycoprotein expression: an experimental study. Nucl Med Biol. 2012;39:671\u20138.","journal-title":"Nucl Med Biol"},{"key":"9739_CR18","first-page":"1303","volume":"34","author":"S Seo","year":"2009","unstructured":"Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, et al. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro. Int J Oncol. 2009;34:1303\u201312.","journal-title":"Int J Oncol"},{"key":"9739_CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1158\/1078-0432.CCR-06-1357","volume":"13","author":"S Seo","year":"2007","unstructured":"Seo S, Hatano E, Higashi T, Hara T, Tada M, Tamaki N, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res. 2007;13:427\u201333.","journal-title":"Clin Cancer Res"},{"key":"9739_CR20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.surg.2008.01.010","volume":"143","author":"S Seo","year":"2008","unstructured":"Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Surgery. 2008;143:769\u201377.","journal-title":"Surgery"},{"key":"9739_CR21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006231-200401000-00004","volume":"25","author":"K Higashi","year":"2004","unstructured":"Higashi K, Ueda Y, Ikeda R, Kodama Y, Guo J, Matsunari I, et al. P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer. Nucl Med Commun. 2004;25:19\u201327.","journal-title":"Nucl Med Commun"},{"key":"9739_CR22","doi-asserted-by":"crossref","unstructured":"Brito AF, Mendes M, Abrantes AM, Tralh\u00e3o JG, Botelho MF. Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)fluoro-D-glucose. Mol Diagn Ther. 2014;18:495\u2013504.","DOI":"10.1007\/s40291-014-0106-3"},{"key":"9739_CR23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00259-003-1204-3","volume":"30","author":"T M\u00e1ri\u00e1n","year":"2003","unstructured":"M\u00e1ri\u00e1n T, Szab\u00f3 G, Goda K, Nagy H, Szincs\u00e1k N, Juh\u00e1sz I, et al. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance. Eur J Nucl Med Mol Imaging. 2003;30:1147\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9739_CR24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejps.2006.02.006","volume":"28","author":"ZT Krasznai","year":"2006","unstructured":"Krasznai ZT, P\u00e9li-Szab\u00f3 J, N\u00e9meth E, Balkay L, Szab\u00f3 G, Goda K, et al. Paclitaxel modifies the accumulation of tumor-diagnostic tracers in different ways in P-glycoprotein-positive and negative cancer cells. Eur J Pharm Sci. 2006;28:249\u201356.","journal-title":"Eur J Pharm Sci"},{"key":"9739_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2014.08.002","volume":"64","author":"ZT Krasznai","year":"2014","unstructured":"Krasznai ZT, Trencs\u00e9nyi G, Krasznai Z, Mikecz P, Nizsal\u00f3czki E, Szal\u00f3ki G, et al. 18FDG a PET tumor diagnostic tracer is not a substrate of the ABC transporter P-glycoprotein. Eur J Pharm Sci. 2014;64:1\u20138.","journal-title":"Eur J Pharm Sci"},{"key":"9739_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood\u2013brain barrier. Neurobiol Dis. 2010;37:13\u201325.","journal-title":"Neurobiol Dis"},{"key":"9739_CR27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/pr.113.007518","volume":"65","author":"J K\u00f6nig","year":"2013","unstructured":"K\u00f6nig J, M\u00fcller F, Fromm MF. Transporters and drug\u2013drug interactions: important determinants of drug disposition and effects. Pharmacol Rev. 2013;65:944\u201366.","journal-title":"Pharmacol Rev"},{"key":"9739_CR28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/brain\/awr298","volume":"135","author":"DME Assema Van","year":"2012","unstructured":"Van Assema DME, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD, et al. Blood\u2013brain barrier P-glycoprotein function in Alzheimer\u2019s disease. Brain. 2012;135:181\u20139.","journal-title":"Brain"},{"key":"9739_CR29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","volume":"365","author":"P Kwan","year":"2011","unstructured":"Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med. 2011;365:919\u201326.","journal-title":"N Engl J Med"},{"key":"9739_CR30","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.neuroimage.2009.09.048","volume":"49","author":"C Foug\u00e8re La","year":"2010","unstructured":"La Foug\u00e8re C, B\u00f6ning G, Bartmann H, W\u00e4ngler B, Nowak S, Just T, et al. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar. NeuroImage. 2010;49:1406\u201315.","journal-title":"NeuroImage"},{"key":"9739_CR31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S1461145709990848","volume":"13","author":"N Tournier","year":"2010","unstructured":"Tournier N, Chevillard L, Megarbane B, Pirnay S, Scherrmann J-M, Decl\u00e8ves X. Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). Int J Neuropsychopharmacol. 2010;13:905\u201315.","journal-title":"Int J Neuropsychopharmacol"},{"key":"9739_CR32","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1002\/jps.21771","volume":"98","author":"N Tournier","year":"2009","unstructured":"Tournier N, Andr\u00e9 P, Blondeel S, Rizzo-Padoin N, du Moulinet d\u2019Hardemarre A, Decl\u00e8ves X, et al. Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood\u2013brain barrier. J Pharm Sci. 2009;98:4650\u201360.","journal-title":"J Pharm Sci"},{"key":"9739_CR33","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s11095-012-0776-7","volume":"29","author":"N Tournier","year":"2012","unstructured":"Tournier N, Cisternino S, Peyronneau M-A, Goutal S, Dolle F, Scherrmann J-M, et al. Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates. Pharm Res. 2012;29:2468\u201376.","journal-title":"Pharm Res"},{"key":"9739_CR34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2967\/jnumed.112.111732","volume":"54","author":"AB Ke","year":"2013","unstructured":"Ke AB, Eyal S, Chung FS, Link JM, Mankoff DA, Muzi M, et al. Modeling cyclosporine A inhibition of the distribution of a P-glycoprotein PET ligand, 11C-verapamil, into the maternal brain and fetal liver of the pregnant nonhuman primate: impact of tissue blood flow and site of inhibition. J Nucl Med. 2013;54:437\u201346.","journal-title":"J Nucl Med"},{"key":"9739_CR35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/clpt.2009.138","volume":"86","author":"P Kannan","year":"2009","unstructured":"Kannan P, John C, Zoghbi SS, Halldin C, Gottesman MM, Innis RB, et al. Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications. Clin Pharmacol Ther. 2009;86:368\u201377.","journal-title":"Clin Pharmacol Ther"},{"key":"9739_CR36","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"9739_CR37","first-page":"1157","volume":"43","author":"MM Graham","year":"2002","unstructured":"Graham MM, Muzi M, Spence AM, O\u2019Sullivan F, Lewellen TK, Link JM, et al. The FDG lumped constant in normal human brain. J Nucl Med. 2002;43:1157\u201366.","journal-title":"J Nucl Med"},{"key":"9739_CR38","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/jcbfm.2008.34","volume":"28","author":"J Cattelotte","year":"2008","unstructured":"Cattelotte J, Andr\u00e9 P, Ouellet M, Bourasset F, Scherrmann J-M, Cisternino S. In situ mouse carotid perfusion model: glucose and cholesterol transport in the eye and brain. J Cereb Blood Flow Metab. 2008;28:1449\u201359.","journal-title":"J Cereb Blood Flow Metab"},{"key":"9739_CR39","first-page":"479","volume":"35","author":"AJ Keyeux","year":"1994","unstructured":"Keyeux AJ, Ochrymowicz-Bemelmans DA, Charlier AA. Technetium-99m-pertechnetate as a whole blood marker for brain perfusion studies. J Nucl Med. 1994;35:479\u201383.","journal-title":"J Nucl Med"},{"key":"9739_CR40","unstructured":"R Core Team (2014) R: A Language and Environment for Statistical Computing. http:\/\/www.R-project.org\/ ."},{"key":"9739_CR41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuroimage.2010.02.013","volume":"51","author":"YT Hong","year":"2010","unstructured":"Hong YT, Fryer TD. Kinetic modelling using basis functions derived from two-tissue compartmental models with a plasma input function: general principle and application to [18F]fluorodeoxyglucose positron emission tomography. NeuroImage. 2010;51:164\u201372.","journal-title":"NeuroImage"},{"key":"9739_CR42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00004647-199607000-00017","volume":"16","author":"SG Hasselbalch","year":"1996","unstructured":"Hasselbalch SG, Knudsen GM, Holm S, Hageman LP, Capaldo B, Paulson OB. Transport of D-glucose and 2-fluorodeoxyglucose across the blood\u2013brain barrier in humans. J Cereb Blood Flow Metab. 1996;16:659\u201366.","journal-title":"J Cereb Blood Flow Metab"},{"key":"9739_CR43","doi-asserted-by":"crossref","unstructured":"Broxterman HJ, Pinedo HM, Schuurhuis GJ, Lankelma J. Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells. Br J Cancer. 1990;62:85\u20138.","DOI":"10.1038\/bjc.1990.234"},{"key":"9739_CR44","doi-asserted-by":"crossref","unstructured":"Giacomini KM, Huang S-M, Tweedie DJ, Benet LZ, Brouwer KLR, Chu X, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9:215\u201336.","DOI":"10.1038\/nrd3028"},{"key":"9739_CR45","doi-asserted-by":"crossref","unstructured":"Quan Y, Jin Y, Faria TN, Tilford CA, He A, Wall DA, et al. Expression profile of drug and nutrient absorption related genes in Madin\u2013Darby canine kidney (MDCK) cells grown under differentiation conditions. Pharmaceutics. 2012;4:314\u201333.","DOI":"10.3390\/pharmaceutics4020314"},{"key":"9739_CR46","doi-asserted-by":"crossref","unstructured":"Furuta M, Nozaki M, Kawashima M, Iimuro M, Okayama A, Fukushima M, et al. Monitoring mitochondrial metabolisms in irradiated human cancer cells with (99m)Tc-MIBI. Cancer Lett. 2004;212:105\u201311.","DOI":"10.1016\/j.canlet.2004.03.002"},{"key":"9739_CR47","doi-asserted-by":"crossref","unstructured":"Cattelotte J, Tournier N, Rizzo-Padoin N, Schinkel AH, Scherrmann J-M, Cisternino S. Changes in dipole membrane potential at the mouse blood\u2013brain barrier enhance the transport of 99mTechnetium Sestamibi more thaninhibiting Abcb1, Abcc1, or Abcg2. J Neurochem. 2009;108:767\u201375.","DOI":"10.1111\/j.1471-4159.2008.05832.x"},{"key":"9739_CR48","doi-asserted-by":"crossref","unstructured":"Litman T, Nielsen D, Skovsgaard T, Zeuthen T, Stein WD. ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines. Biochim Biophys Acta. 1997;1361:147\u201358.","DOI":"10.1016\/S0925-4439(97)00025-2"},{"key":"9739_CR49","doi-asserted-by":"crossref","unstructured":"Martell RL, Slapak CA, Levy SB. Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3. Br J Cancer. 1997;75:161\u20138.","DOI":"10.1038\/bjc.1997.27"},{"key":"9739_CR50","doi-asserted-by":"crossref","unstructured":"Noda A, Takamatsu H, Minoshima S, Tsukada H, Nishimura S. Determination of kinetic rate constants for 2-[18F]fluoro-2-deoxy-d-glucose and partition coefficient of water in conscious macaques and alterations in aging or anesthesia examined on parametric images with an anatomic standardization technique. J Cereb Blood Flow Metab. 2003;23:1441\u20137.","DOI":"10.1097\/01.WCB.0000090623.86921.47"},{"key":"9739_CR51","doi-asserted-by":"crossref","unstructured":"Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire P, Missimer J, et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol. 1997;7:9\u201324.","DOI":"10.1016\/S0924-977X(96)00039-9"},{"key":"9739_CR52","doi-asserted-by":"crossref","unstructured":"Cattelotte J, Tournier N, Rizzo-Padoin N, Schinkel AH, Scherrmann J-M, Cisternino S. Changes in dipole membrane potential at the mouse blood\u2013brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2. J Neurochem. 2009;108:767\u201375.","DOI":"10.1111\/j.1471-4159.2008.05832.x"},{"key":"9739_CR53","doi-asserted-by":"crossref","unstructured":"Cisternino S, Mercier C, Bourasset F, Roux F, Scherrmann J-M. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood\u2013brain barrier. Cancer Res. 2004;64:3296\u2013301.","DOI":"10.1158\/0008-5472.CAN-03-2033"},{"key":"9739_CR54","doi-asserted-by":"crossref","unstructured":"Hosten B, Boisgard R, Jacob A, Goutal S, Saubam\u00e9a B, Doll\u00e9 F, et al. [11C]befloxatone brain kinetics is not influenced by Bcrp function at the blood\u2013brain barrier: a PET study using Bcrp TGEM knockout rats. Eur J Pharm Sci. 2013;50:520\u20135.","DOI":"10.1016\/j.ejps.2013.08.015"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-015-9739-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-015-9739-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-015-9739-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T04:11:51Z","timestamp":1566360711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-015-9739-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,26]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["9739"],"URL":"https:\/\/doi.org\/10.1208\/s12248-015-9739-3","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,26]]}}}